NEW

GE HealthCare Preps for SIR 2024

GE HealthCare will showcase its latest technologies in image guiding solutions, surgery, ultrasound and CT-navigation at the upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting taking place March 23-28 in Salt Lake City, Utah. The...

Samsung Accepts Healthcare Innovator Award

Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business, was awarded HHM Health’s Healthcare Innovator Award

AHRA Co-Founder Passes Away

On March 2, 2024, Louise Broadley passed away at 101 years old. AHRA shared the news via an email and website post that reads, “She was a noble woman, who not only achieved many milestones within the imaging profession, but likewise paved the way for aspiring leaders...

Artificial Intelligence Paper Outlines FDA’s Approach to Protect Public Health and Promote Ethical Innovation

Today, the U.S. Food and Drug Administration (FDA) released its “Artificial Intelligence and Medical Products: How CBER, CDER, CDRH, and OCP are Working Together,” which outlines how FDA’s medical product centers are working together to protect public health while...

Joint Commission Issues Statement on Standards Review

The Joint Commission President and Chief Executive Officer Jonathan B. Perlin, MD, Ph.D., MSHA, MACP, FACMI, shared the following information on September 13, 2022.

Today we announced the beginning of a review of all Joint Commission “above-and-beyond” requirements, those that go beyond the Centers for Medicare & Medicaid Services (CMS) Conditions of Participation (CoPs) and are not on crosswalks to the CoPs.

During the COVID-19 public health emergency (PHE), CMS put many requirements on hold. As the PHE nears its end, CMS has been reviewing the waived requirements to determine whether some should be permanently retired. The Joint Commission will similarly address the necessity of our own unique requirements.

Specifically, we will review each requirement to answer:

  • Does the requirement still address an important quality and safety issue?
  • Is the requirement redundant?
  • Are the time and resources needed to comply with the requirement commensurate with the estimated benefit to patient care and health outcomes?

In addition to a direct review of each requirement, we will conduct quantitative analyses of scoring patterns and tests for redundancy. Where necessary, we also will conduct literature and field reviews and engage experts within the field.

American health care still has a long way to go to fully recover from COVID-19 and to reach a new equilibrium – especially as we are now witnessing secondary effects from the pandemic. At The Joint Commission, we are committed to working with health care organizations and other stakeholders to help address the many challenges health care is facing, as well as to making our own requirements as efficient and impactful on patient safety and quality as possible.

For more information, visit jointcommission.org.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

Open